- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
ADCYAP1 Antibody / Pituitary Adenylate Cyclase Activating Polypeptide Antibody recognizes ADCYAP1, the gene encoding pituitary adenylate cyclase activating polypeptide (PACAP), a highly conserved neuropeptide precursor that is proteolytically processed to generate the biologically active PACAP-38 and PACAP-27 peptides. ADCYAP1 is widely expressed throughout the central and peripheral nervous systems as well as in endocrine, gastrointestinal, and reproductive tissues. Through activation of PAC1, VPAC1, and VPAC2 receptors, PACAP regulates cyclic AMP signaling and numerous downstream cellular pathways. An ADCYAP1 Antibody is a valuable tool for investigating neuropeptide biology, neuronal communication, and neuroendocrine signaling.
Pituitary Adenylate Cyclase Activating Polypeptide functions as a multifunctional signaling molecule involved in neurotransmission, hormone secretion, neuronal differentiation, synaptic plasticity, circadian rhythm regulation, and cellular survival. The peptide also influences immune responses, vascular tone, metabolism, and gastrointestinal physiology. Because ADCYAP1 expression changes in response to neuronal injury and physiological stress, it has become an important target for studies of neuroprotection, tissue repair, and adaptive cellular signaling. The broad distribution and diverse biological activities of Pituitary Adenylate Cyclase Activating Polypeptide continue to drive interest across neuroscience and cell biology research.
Altered ADCYAP1 signaling has been associated with migraine, neurodegenerative disease, ischemic injury, psychiatric disorders, chronic pain, inflammation, metabolic dysfunction, and several cancers. Changes in PACAP expression have also been linked to stress-related disorders and abnormalities in autonomic regulation. Consequently, an ADCYAP1 Antibody is widely used to investigate disease-associated signaling pathways, characterize tissue-specific expression, and examine mechanisms underlying nervous system development and cellular homeostasis.
ADCYAP1 antibodies are suitable for applications including Western blotting, immunohistochemistry, immunofluorescence, flow cytometry, and related protein detection methods when validated for the specific application. NSJ Bioreagents provides carefully validated antibodies to support investigations of neuropeptide signaling, neuronal development, neuroendocrine regulation, and disease biology. An ADCYAP1 Antibody / Pituitary Adenylate Cyclase Activating Polypeptide Antibody is a valuable research reagent for detecting ADCYAP1 expression and advancing studies of PACAP biology, neuronal signaling, and neuroprotective mechanisms.
Explore our Neuroscience Antibodies page to discover validated antibodies for ADCYAP1 and other proteins involved in neuropeptide signaling, neuronal development, synaptic communication, neuroendocrine regulation, and nervous system research.
The stated application concentrations are suggested starting points. Titration of the ADCYAP1 Antibody / Pituitary Adenylate Cyclase Activating Polypeptide Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A portion of amino acids 148-176 from the human protein was used as the immunogen for the ADCYAP1 antibody.
Aliquot the ADCYAP1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
ADCYAP1 antibody, Pituitary Adenylate Cyclase Activating Polypeptide antibody, PACAP antibody, PACAP38 precursor antibody, Adenylate Cyclase Activating Polypeptide antibody, Prepro-PACAP antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.